PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2016

Apr 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2016-04-15

Reporting Person: PHILLIPS RICHARD BENTON (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-15	STOCK OPTION (RIGHT TO BUY)	$31.85	A	25000	Acquired	2026-04-14	COMMON STOCK (25000)	Direct

Footnotes

F1: The vesting commencement date ("VCD") of the option is April 15, 2016. 100% of the shares of common stock underlying the option shall vest on the earlier of (i) the one-year anniversary of the VCD and (ii) the date on which a new Head of Regulatory Affairs commences employment with the Issuer, subject to the Reporting Person's continued employment with the Issuer through the vesting date.